Literature DB >> 29759501

Assessment of Atrial Fibrillation-Specific Symptoms Before and 2 Years After Atrial Fibrillation Ablation: Do Patients and Physicians Differ in Their Perception of Symptom Relief?

Anna Björkenheim1, Axel Brandes2, Anders Magnuson3, Alexander Chemnitz2, Lena Svedberg4, Nils Edvardsson5, Dritan Poçi4.   

Abstract

OBJECTIVES: The aim of this study was to evaluate patient-reported and physician-assessed atrial fibrillation (AF)-related symptoms after AF ablation.
BACKGROUND: Success of AF ablation is usually defined as freedom from AF, although symptom relief is often patients' desire.
METHODS: Symptom relief was assessed as perceived by patients using the short, validated, AF-specific symptom questionnaire AF6 and as classified by physicians using the European Heart Rhythm Association (EHRA) classification at baseline and 6, 12, and 24 months after AF ablation. Recurrence of arrhythmia was documented by continuous electrocardiographic monitoring.
RESULTS: In total, 54 patients completed the 24-month follow-up. All 6 items on the AF6, AF6 sum score, and EHRA class improved significantly over time. The greatest improvement was seen during the first 6 months after ablation, but AF6 scores showed continued improvement up to 12 months, in contrast to EHRA class. There was a low correlation between AF6 score and EHRA class, but the predictive ability was low. Both AF6 scores and EHRA class were significantly correlated with AF burden at all times after ablation. A change of >9 points in AF6 sum score corresponded to a meaningful reduction in symptom severity.
CONCLUSION: Patient-reported and physician-assessed outcomes were both useful in assessing symptom relief after AF ablation, although patient-reported outcomes were more sensitive tools. There was also a discrepancy between patient-reported and physician-assessed outcomes after ablation. Freedom from AF and a low AF burden most often resulted in a reduction of symptoms, but symptom relief also occurred despite little effect on the arrhythmia.
Copyright © 2017 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  atrial fibrillation; catheter ablation; symptoms

Mesh:

Year:  2017        PMID: 29759501     DOI: 10.1016/j.jacep.2017.04.003

Source DB:  PubMed          Journal:  JACC Clin Electrophysiol        ISSN: 2405-500X


  8 in total

Review 1.  Tackling Patient-Reported Outcomes in Atrial Fibrillation and Heart Failure: Identifying Disease-Specific Symptoms?

Authors:  Benjamin A Steinberg; Jonathan P Piccini
Journal:  Cardiol Clin       Date:  2019-05       Impact factor: 2.213

2.  Patient-Defined Outcome Endpoints: A Paradigm Shift in Evaluating Atrial Fibrillation Ablation Efficacy.

Authors:  Devika Nair; Gregory F Michaud; Kerri L Cavanaugh
Journal:  Heart Lung Circ       Date:  2021-06-03       Impact factor: 2.975

3.  Predictors of recurrence of atrial fibrillation within the first 3 months after ablation.

Authors:  Matthias Daniel Zink; Winnie Chua; Stef Zeemering; Luigi di Biase; Bayes de Luna Antoni; Callans David; Gerhard Hindricks; Karl Georg Haeusler; Hussein R Al-Khalidi; Jonathan P Piccini; Lluís Mont; Jens Cosedis Nielsen; Luis Alberto Escobar; Joseph de Bono; Isabelle C Van Gelder; Tom de Potter; Daniel Scherr; Sakis Themistoclakis; Derick Todd; Paulus Kirchhof; Ulrich Schotten
Journal:  Europace       Date:  2020-09-01       Impact factor: 5.214

4.  Improvement in Atrial Fibrillation-Related Symptoms After Cardioversion: Role of NYHA Functional Class and Maintenance of Sinus Rhythm.

Authors:  Maria Ferre-Vallverdu; Carmen Ligero; Rafael Vidal-Perez; Antoni Martinez-Rubio; Xavier Vinolas; Josep M Alegret
Journal:  Clin Interv Aging       Date:  2021-04-29       Impact factor: 4.458

5.  Symptoms and health-related quality of life 5 years after catheter ablation of atrial fibrillation.

Authors:  Ulla Walfridsson; Anders Hassel Jönsson; Lars O Karlsson; Ioan Liuba; Henrik Almroth; Emma Sandgren; Håkan Walfridsson; Emmanouil Charitakis
Journal:  Clin Cardiol       Date:  2021-12-16       Impact factor: 2.882

6.  Advanced glycation end products predict long-term outcome of catheter ablation in paroxysmal atrial fibrillation.

Authors:  Allan Bohm; Lubos Urban; Lubomira Tothova; Ljuba Bacharova; Peter Musil; Jan Kyselovic; Peter Michalek; Tomas Uher; Branislav Bezak; Peter Olejnik; Robert Hatala
Journal:  J Interv Card Electrophysiol       Date:  2021-03-10       Impact factor: 1.900

7.  Patients with symptomatic permanent atrial fibrillation show quantitative signs of pain sensitisation.

Authors:  Adam Jackson; Ole Frobert; Dennis Boye Larsen; Lars Arendt-Nielsen; Anna Björkenheim
Journal:  Open Heart       Date:  2021-06

8.  Patient-Reported Outcomes in Relation to Continuously Monitored Rhythm Before and During 2 Years After Atrial Fibrillation Ablation Using a Disease-Specific and a Generic Instrument.

Authors:  Anna Björkenheim; Axel Brandes; Anders Magnuson; Alexander Chemnitz; Nils Edvardsson; Dritan Poçi
Journal:  J Am Heart Assoc       Date:  2018-02-24       Impact factor: 5.501

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.